StonvexLoading…
StonvexCore line items from EFXT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $2.57B | $2.41B | $2.34B |
Operating Income | $306.00M | $173.00M | $121.00M |
Net Income | $64.00M | $32.00M | $-83.00M |
EPS (Diluted) | $0.52 | $0.26 | $-0.67 |
Total Assets | $2.69B | $2.79B | $2.96B |
Total Liabilities | $1.60B | $1.74B | $1.90B |
Cash & Equivalents | $81.00M | $92.00M | $95.00M |
Free Cash Flow OCF − CapEx | $326.00M | $308.00M | $190.00M |
Shares Outstanding | Not available | Not available | Not available |